Cite
Anti-seizure mechanisms of midazolam and valproate at the β2(L51M) variant of the GABAA receptor.
MLA
Kuanyshbek, Alibek, et al. “Anti-Seizure Mechanisms of Midazolam and Valproate at the Β2(L51M) Variant of the GABAA Receptor.” Neuropharmacology, vol. 221, Dec. 2022, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.neuropharm.2022.109295.
APA
Kuanyshbek, A., Wang, M., Andersson, Å., Tuifua, M., Palmer, E. E., Sachdev, R. K., Mu, T.-W., Vetter, I., & Keramidas, A. (2022). Anti-seizure mechanisms of midazolam and valproate at the β2(L51M) variant of the GABAA receptor. Neuropharmacology, 221, N.PAG. https://doi.org/10.1016/j.neuropharm.2022.109295
Chicago
Kuanyshbek, Alibek, Meng Wang, Åsa Andersson, Marie Tuifua, Elizabeth E. Palmer, Rani K. Sachdev, Ting-Wei Mu, Irina Vetter, and Angelo Keramidas. 2022. “Anti-Seizure Mechanisms of Midazolam and Valproate at the Β2(L51M) Variant of the GABAA Receptor.” Neuropharmacology 221 (December): N.PAG. doi:10.1016/j.neuropharm.2022.109295.